Free Trial

U.S. Physical Therapy, Inc. (NYSE:USPH) Sees Large Increase in Short Interest

U.S. Physical Therapy logo with Medical background

Key Points

  • U.S. Physical Therapy, Inc. (NYSE:USPH) experienced a 320.7% increase in short interest in July, with a total of 577,600 shares shorted as of July 15.
  • Insider transactions revealed that Director Nancy Ham sold 400 shares at an average price of $78.01, decreasing her ownership by 13.36%.
  • Despite a 4.0% decline in stock value recently, U.S. Physical Therapy reported strong quarterly earnings, with $0.48 EPS exceeding expectations and revenue up 18% year-over-year.
  • Looking to export and analyze U.S. Physical Therapy data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) saw a large growth in short interest in July. As of July 15th, there was short interest totaling 577,600 shares, agrowthof320.7% from the June 30th total of 137,300 shares. Based on an average daily trading volume, of 166,700 shares, the short-interest ratio is currently 3.5 days. Based on an average daily trading volume, of 166,700 shares, the short-interest ratio is currently 3.5 days.

Insider Activity at U.S. Physical Therapy

In other news, Director Nancy Ham sold 400 shares of the business's stock in a transaction dated Thursday, June 12th. The stock was sold at an average price of $78.01, for a total value of $31,204.00. Following the transaction, the director directly owned 2,594 shares of the company's stock, valued at $202,357.94. The trade was a 13.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.00% of the company's stock.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of hedge funds have recently bought and sold shares of USPH. GAMMA Investing LLC increased its stake in shares of U.S. Physical Therapy by 27,856.8% in the 1st quarter. GAMMA Investing LLC now owns 12,301 shares of the company's stock worth $890,000 after acquiring an additional 12,257 shares during the last quarter. Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy in the 4th quarter valued at $84,000. Wells Fargo & Company MN increased its position in shares of U.S. Physical Therapy by 2.2% during the 4th quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock worth $10,021,000 after purchasing an additional 2,465 shares during the last quarter. Deutsche Bank AG lifted its position in U.S. Physical Therapy by 49.3% in the fourth quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock valued at $1,169,000 after buying an additional 4,350 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in U.S. Physical Therapy by 2.3% during the first quarter. Principal Financial Group Inc. now owns 84,964 shares of the company's stock worth $6,148,000 after buying an additional 1,873 shares during the period.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. JMP Securities reissued a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. Wall Street Zen raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Finally, Barrington Research restated an "outperform" rating and issued a $98.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, July 1st. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $109.00.

Read Our Latest Report on USPH

U.S. Physical Therapy Price Performance

Shares of USPH stock traded up $13.37 on Thursday, hitting $86.06. 199,281 shares of the stock traded hands, compared to its average volume of 140,174. U.S. Physical Therapy has a 52 week low of $62.77 and a 52 week high of $101.19. The firm has a 50 day simple moving average of $75.99 and a two-hundred day simple moving average of $77.20. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of 39.47, a PEG ratio of 3.49 and a beta of 1.45.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The firm had revenue of $197.34 million during the quarter, compared to analyst estimates of $190.24 million. During the same period in the previous year, the firm earned $0.73 earnings per share. The business's revenue was up 18.0% on a year-over-year basis. As a group, equities research analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Stockholders of record on Friday, August 22nd will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.1%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 82.57%.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid
NVIDIA Earnings: All Signs Point to More Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines